Cannabis

Wednesday Aug 02, 2023 - 12:29 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Designing Human Clinical Study of DehydraTECH-CBD for Weight Loss, Diabetes Control

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today reported its intention to conduct a human clinical study to examine DehydraTECH-CBD for purposes of diabetes control and weight loss. Lexaria previously announced that, in its pre-clinical diabetes study DIAB-A22-1 in obese diabetic-conditioned animals, DehydraTECH-CBD achieved each of the following: lowered blood glucose levels by 19.9%; lowered overall body weight by 7%…

Wednesday Aug 02, 2023 - 11:23 am

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Expands Phase 2 Trial to Add New Site

IGC Pharma (NYSE American: IGC) today announced the addition of an important trial site at the University of Puerto Rico network as an expansion of its ongoing phase 2 clinical trial investigating lead drug asset, IGC-AD1, as a treatment for lowering agitation in patients with Alzheimer’s disease. According to clinicaltrials.gov, IGC-AD1 is the only natural THC-based investigational drug undergoing FDA trials. The therapy relies on…

Friday Jul 28, 2023 - 12:34 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW) Announces New Subsidiary, Provides Update on Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has incorporated a new wholly owned subsidiary: Lexaria Nutraceutical Corp., or LEXX Nutra. According to the announcement, LEXX Nutra was established to support Lexaria’s overall strategy of maximizing the potential for its patented DehydraTECH(TM) technology in a variety of markets. The company issued an exclusive perpetual license to LEXX Nutra, giving the new subsidiary rights…

Friday Jul 21, 2023 - 11:10 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs. The company today announced that Jerry Griffin, VP of Sales and Marketing for InMed’s subsidiary BayMedica LLC, a leading supplier of bioidentical rare cannabinoids to the health and wellness (“H&W”) market, will be participating in a fireside chat with Water Tower Research on July…

Thursday Jul 20, 2023 - 10:30 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today provided a commercial and manufacturing update on its subsidiary BayMedica LLC, a leading supplier of bioidentical rare cannabinoids to the health and wellness (“H&W”) market. Among the highlights, the company reported a 123% quarter-over-quarter increase in revenues. “We are very encouraged to see another…

Wednesday Jul 19, 2023 - 11:24 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Portfolio in Oral Nicotine Delivery Sector

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it was granted a strategically important new patent in the oral nicotine sector by the United States Patent and Trademark Office (“USPTO”). According to the update, U.S. patent #11,700,875 Compositions and Methods For Sublingual Delivery of Nicotine includes claims for many types of nicotine, including nicotine benzoate, nicotine ditartrate, nicotine…

Tuesday Jul 18, 2023 - 11:01 am

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Presenting 6 Posters on Its Lead Therapeutic Candidate at AAIC 2023

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, today announced that it is presenting six in-person posters highlighting data from its phase 1 clinical trials investigating the company’s lead therapeutic candidate, IGC-AD1, at the Alzheimer’s Association International Conference (“AAIC”). The event is taking place July 16-20, 2023, in Amsterdam, Netherlands. “We are honored to have six posters accepted for presentation at AAIC 2023, a…

Friday Jul 14, 2023 - 2:22 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Study Reveals ‘Most Convincing Evidence’ of CBD’s Anti-Inflammatory Actions in Humans

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced additional findings from its human clinical study HYPER-H21-4, completed last year. “The hypertension study sought to evaluate DehydraTECH-processed cannabidiol (“CBD”) as a potential antihypertensive medication and already achieved primary efficacy and safety objectives. According to the company, the study also demonstrated significant reductions in several pro-inflammatory biomarkers – interleukin (‘IL’) 8, 10 and 18 – known to be…

Thursday Jul 13, 2023 - 2:35 pm

InvestorNewsBreaks — Lift Events and Experiences Announces Inaugural US Cannabis Food & Beverage Event

Lift Events and Experiences will be hosting its first U.S. event: Lift San Francisco. The two-day event will be held on Aug. 3–4, 2023, at the Moscone Convention Center in San Francisco. According to the announcement, the event will feature the inaugural Taste at Lift: Cannabis Food & Beverage Experience, which is designed to allow attendees to participate in exclusive demos, in-depth presentations and expert panels…

Thursday Jul 06, 2023 - 12:38 pm

InvestorNewsBreaks – Alt Pro Expo to Take the Stage in Dallas

Following successful events in North and South America, the Alternative Products Expo (“Alt Pro Expo”), a production of ZJ Events, is coming to the vibrant city of Dallas, Texas. The Dallas Expo 2023 is set to take place at the Kay Bailey Hutchison Convention Center in the heart of downtown from July 13-15, 2023. The center of retail distribution in the American southwest, Dallas is…

Monday Jul 03, 2023 - 12:09 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Processed Formulation Results in Higher Concentration, Delivery of Estrogen Hormone than Control

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently completed its animal study HOR-A22-1, which showed that the company’s patented DehydraTECH(TM) technology platform significantly enhanced the oral delivery of the estrogen hormone estradiol. “The study found that the DehydraTECH-estradiol composition resulted in a maximum concentration in the bloodstream (‘Cmax’) of 5.65 ng/mL, which was approximately 900% higher than the control formulation’s…

Thursday Jun 22, 2023 - 11:37 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) 755-201-EB Trial Demonstrates Clinically Important Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced safety and efficacy results from its phase 2 clinical trial. The purpose of the trial, called “755-201-EB,” was to evaluate the safety of INM-755 CBN cream, which consists of the control cream plus the active pharmaceutical ingredient CBN, and obtain preliminary evidence of…

Tuesday Jun 20, 2023 - 2:04 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands IP Portfolio with Four New Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of four newly granted patents. The company secured two new Canadian patents, its 18th in its patent family No. 1: Food and Beverage Compositions Infused with Lipophilic Active Agents and Methods of Use Thereof, and No. 8 in its: Compositions Infused with Nicotine Compounds and Methods of Use Thereof.…

Friday Jun 16, 2023 - 11:02 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on Promising Results from Diabetes Animal Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is releasing additional findings from its DIAB-A22-1 study, a diabetes animal study designed to evaluate the company’s proprietary DehydraTECH-CBD. DehydraTECH is a patented drug-delivery formulation and processing platform technology developed by Lexaria. The company noted that in addition to the three positive outcomes reported earlier — weight loss in obese diabetic-conditioned animals and improved triglyceride and…

Monday Jun 12, 2023 - 12:55 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints Experienced Financial Professional as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the appointment of a new chief financial officer. Effective immediately, Mike Shankman will serve as outsourced CFO. An experienced accounting and finance professional, Shankman has held senior positions with companies in the biotechnology, medical devices and software-as-a-service industries. As a consultant with NOW CFO, one of his current clients is a…

Friday Jun 09, 2023 - 10:39 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Portfolio of Worldwide Patents

Lexaria Bioscience Corp. (NASDAQ: LEXX), the global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs through its patented DehydraTECH(TM) technology, recently announced it had received notification of four newly awarded or allowed patents. “The new patents will add to Lexaria’s growing portfolio and, upon award, will bring the total number of patents granted worldwide to 32, with several…

Tuesday Jun 06, 2023 - 12:30 pm

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Receives Notice of Allowance for Patent on IGC-501

IGC Pharma (NYSE American: IGC) today announced its receipt of a Notice of Allowance from the Commissioner of Patents, Canada, for its patent filing on the use of cannabinoids in the treatment of seizures (“IGC-501”). The formulation additionally received an intent to grant from the European Patent Office. With these and a previous award, the formulation for treating seizures is protected in the U.S., Canada…

Thursday Jun 01, 2023 - 10:37 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Sponsored Research Presented at Canadian Neuroscience Meeting

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids, today announced that results from a neurodegenerative disease study were presented in a scientific poster at the Canadian Neuroscience Meeting in Montreal from May 28-31, 2023. The InMed sponsored research demonstrated the ability of a specific rare cannabinoid (“pCBx”) in InMed’s 900 Series library of potential candidates that…

Friday May 26, 2023 - 11:49 am

InvestorNewsBreaks – Bright Green Corporation (NASDAQ: BGXX) Announces Pricing of $3.5M Private Placement

Bright Green (NASDAQ: BGXX) is one of the few companies selected by the U.S. government to grow, manufacture and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. The company recently announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 3,684,210 shares of common stock and warrants to…

Thursday May 25, 2023 - 11:12 am

InvestorNewsBreaks – Jaxx Cannabis Owner, Veteran and Cannabis Advocate Featured in Recent Episode of The Plant Lady

Female empowerer and owner of Jaxx Cannabis, JM Balbuena, was featured in a recent episode of The Plant Lady podcast. JM joined host Jackie Bryant to discuss her wellness brand and dispensary’s humble beginnings in San Diego county, which wanted to scrub cannabis culture from its image, to the company’s success, which JM attributes much to patience and working for the system instead of against…

Tuesday May 23, 2023 - 1:29 pm

InvestorNewsBreaks – GRN Holding Corporation (GRNF), Marijuana Inc. Complete Merger, Positioning as Frontrunner in the Cannabis Industry

GRN Holding Corporation (OTC: GRNF) today announced successful completion of its merger with Marijuana Inc., solidifying a position as a dominant player in the cannabis industry. The milestone achievement marks a significant step forward in the shared vision of delivering high-quality cannabis products and driving innovation in the market. “We are delighted to announce the successful completion of the merger between GRN Holding Corporation and…

Tuesday May 23, 2023 - 1:23 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Findings from DehydraTECH-CBD Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced additional findings from last year’s human clinical study HYPER-H21-4. The findings demonstrate significant reductions in several pro-inflammatory biomarkers known to be linked to cardiovascular disease (“CVD”) and a host of other conditions. “There is some pre-clinical evidence for the anti-inflammatory actions of CBD, but this is likely the most convincing evidence…

Friday May 19, 2023 - 12:01 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) CEO Featured in Upcoming Water Tower Research Fireside Chat

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be represented at an upcoming Water Tower Research Fireside Chat Series. The company announced that CEO Eric A. Adams will be the featured speaker at the May 23, 2023, fireside chat; the event is slated to begin at 1 p.m. ET. During the chat,…

Thursday May 18, 2023 - 12:05 pm

InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Announces Participation at Upcoming LD Micro Invitational

IGC Pharma (NYSE American: IGC) will be presenting at the 13th annual LD Micro Invitational, which is slated for June 6–8, 2023, in Los Angeles. IGC Pharma CEO Ram Mukunda and PFO Claudia Grimaldi will be leading the presentation, which is scheduled to begin at 3 p.m. PT on June 6. The event is in person, although individual presentations can be viewed virtually. An estimated…

Monday May 15, 2023 - 2:57 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 2023 Financial Results, Provides Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced financial results for the third quarter of the fiscal year 2023, which ended March 31, 2023. “The third quarter of fiscal year 2023 was an important period for InMed, as we achieved several key milestones across our different business segments, including completing enrollment…

Friday May 12, 2023 - 10:57 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures $2M in Public Offering

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced the closing of its public offering of 2,106,000 units, with each consisting of one share of common stock and one warrant to purchase one share of common stock. Each unit was sold at a public offering price of $0.95. The warrants are immediately exercisable at a price of $0.95 per share…

Thursday May 11, 2023 - 12:38 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Completion of cGMP Manufacturing for Upcoming Clinical Trial

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced completion of batch manufacturing of the DehydraTECH(TM)-processed cannabidiol (“CBD”) and placebo materials for its upcoming U.S. phase 1b hypertension clinical trial HYPER-H23-1. According to the update, Lexaria retained the services of a U.S. contract manufacturing organization to produce the materials compliant with current Good Manufacturing Practice (“cGMP”) regulations as mandated by…

Wednesday May 10, 2023 - 12:43 pm

InvestorNewsBreaks – Lift 2023 Event to Return to the Heart of Downtown Toronto

Lift Events & Experiences, Canada’s No. 1 cannabis conference and trade show series, today announced its return to the Metro Toronto Convention Centre (“MTCC”), a top-of-class venue for business event organizers, located in the heart of downtown Toronto. Lift Toronto 2023, slated to take place on June 1-3, is expected to attract representatives from more than 150 companies within the cannabis-value chain, 140+ renowned industry…

Wednesday May 10, 2023 - 12:32 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Results of 2023 Annual Meeting

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the results of the 2023 Annual Meeting. According to the update, the company held the meeting at 1:00 p.m. PT on May 9, 2023, whereby there were 3,372,024 shares of the company represented in person or by proxy, constituting 56.3% of the company's issued share capital as of the meeting date…

Tuesday May 09, 2023 - 11:19 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Pricing on Current Public Offering

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced the pricing of its public offering, which consists of 2,106,000 units, with each unit including one share of common stock (or one prefunded warrant to purchase one share of common stock in lieu thereof) and one warrant to purchase one share of common stock. According to the announcement, each until will be available…

Monday May 08, 2023 - 2:13 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Dosing Completed on Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has completed dosing for 36 subjects in its human clinical oral nicotine study: NIC-H22-1. According to the announcement, the study is the result of the focus Lexaria has had for years on oral nicotine formulations as an alternative to vaping or smoking; the company noted that results from the study could lead to more rapid…

Friday May 05, 2023 - 10:34 am

InvestorNewsBreaks – BizCann Expo Shares Agenda Details for Upcoming Colombian Cannabis Expo

BizCann Expo, hosted by ZJ Events, is gearing up for its next event to be held May 21–22, 2023, in Medellín, Colombia. A premier cannabis event in South and Latin America, BizCann is designed to provide key information on innovation, entrepreneurship, and education on all aspects of the cannabis sector. This year’s two-day agenda features an impressive array of presentations from more than 20 speakers,…

Wednesday May 03, 2023 - 1:57 pm

InvestorNewsBreaks — AROYA Notes Anniversary of Nonprofit Freedom Grams, Celebrates Growing Awareness of Initiative

AROYA, a division of ADDIUM Inc., is noting the one-year anniversary of nonprofit cannabis brand, Freedom Grams. The brand was created by a coalition of AROYA, retailer and manufacturer GABY Inc. and nonprofit Last Prisoner Project. According to the announcement, Freedom Grams has become a strong advocate for the release of more than 40,000 people in the United States who are still Incarcerated for nonviolent cannabis…

Wednesday May 03, 2023 - 12:57 pm

InvestorNewsBreaks – Advanced Container Technologies Inc. (ACTX) GrowPods Ideal Options for Academic Research, Education

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, is announcing that its modular hydroponic farms are available for research and educational purposes. The company observed that its GrowPods offer the perfect environment for college and university studies and research focused on controlled environment agriculture (“CEA”) and farming. According to the announcement, universities are at the “forefront of…

Monday Apr 24, 2023 - 1:07 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards CRO Contract for Upcoming Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it awarded the contract for clinical research organization (“CRO”) services to California-based InClin, Inc. for its expected upcoming Food and Drug Administration (“FDA”)-registered, U.S. phase 1b Investigational New Drug (“IND”) hypertension study HYPER-H23-1 with its patented DehydraTECH-powered cannabidiol (“DehydraTECH-CBD”). According to the announcement, HYPER-H23-1 is entitled “A Phase 1b Randomized,…

Thursday Apr 20, 2023 - 10:39 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expanding Portfolio with Four New Patents

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has received notifications of four new patents either awarded or allowed. In Japan, the company secured a new patent under its Patent Family #3: Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Agents. This is Lexaria’s fifth awarded patent in Japan, providing strength to its growing Japanese patent portfolio. In…

Monday Apr 17, 2023 - 1:22 pm

InvestorNewsBreaks – Prime Harvest Inc. Eyes Continued Growth and Expansion with Recently Launched Reg A+ Offering

Prime Harvest, a tech-focused legal cannabis enterprise and parent company to SoCal’s premier dispensary JAXX Cannabis, recently launched Weed 4 The People – the company’s Reg A+ offering that allows the public to own a piece of the company for as little as $4.20 per share at a minimum of 100 shares. “Prime Harvest aims to raise upwards of $42M to fund the expansion of…

Friday Apr 14, 2023 - 12:52 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Positive Results in First Diabetes Study

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is increasing the bioavailability of and improving the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery with its patented DehydraTECH(TM). “Most recently, a company announcement indicates that a just-completed DIAB-A22-1 diabetes study has produced at least three positive outcomes, including weight loss in obese diabetic-conditioned animals…

Thursday Apr 13, 2023 - 1:25 pm

InvestorNewsBreaks — AROYA Releases OpenSprinkler Integration, Empowers Cannabis Growers to ‘Not Only Survive, But Also Thrive’

AROYA, a division of ADDIUM Inc., announced a wide release of its integration with the controller OpenSprinkler; the integration empowers growers by providing data to guide their crop-steering decisions while also simplifying an additional aspect of cannabis cultivation. According to the announcement, the release brings added visibility and data-driven control to commercial cultivation and cultivators’ irrigation strategies; the announcement also noted that an estimated 30-40%…

Tuesday Apr 11, 2023 - 1:23 pm

InvestorNewsBreaks – IBN, CannabisNewsWire to Drive Reach of Lift Toronto 2023

IBN (“InvestorBrandNetwork”), an innovative content distributor and multifaceted communications organization with 50+ brands including CannabisNewsWire, today announced its latest event collaboration with the organizers of Lift Toronto, which will return to the iconic Metro Toronto Convention Centre in Toronto, Ontario, on June 1-3, 2023. Lift Toronto is projected to showcase 150-plus exhibiting companies, 140-plus speakers and featured panelists and draw up to 5,000 attendees to…

InvestorNewsBreaks

NewsBreak Category: Cannabis

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions